| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 3.982 | 15.692 | 18.789 | 29.271 | 49.530 | 147.254 | 191.903 |
| Total Income - EUR | - | 0 | 0 | 3.982 | 18.013 | 22.729 | 30.997 | 49.864 | 147.258 | 191.905 |
| Total Expenses - EUR | - | 448 | 105 | 1.475 | 7.362 | 13.726 | 19.607 | 40.954 | 93.499 | 137.904 |
| Gross Profit/Loss - EUR | - | -448 | -105 | 2.507 | 10.651 | 9.003 | 11.390 | 8.909 | 53.759 | 54.001 |
| Net Profit/Loss - EUR | - | -448 | -105 | 2.388 | 10.229 | 8.572 | 10.768 | 7.979 | 52.601 | 48.359 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 4 |
Check the financial reports for the company - Aprophysio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 2.308 | 1.900 | 932 | 28.173 | 34.561 | 30.367 |
| Current Assets | - | 125 | 114 | 2.424 | 13.908 | 21.004 | 19.456 | 9.667 | 21.033 | 27.287 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 96 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 7.146 | 4.352 | 21.852 |
| Cash | - | 125 | 114 | 2.424 | 13.908 | 21.004 | 19.456 | 2.521 | 16.585 | 5.435 |
| Shareholders Funds | - | -403 | -501 | 1.896 | 12.088 | 14.912 | 19.790 | 8.027 | 52.650 | 48.407 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 528 | 615 | 529 | 264 | 5.995 | 286 | 29.813 | 2.945 | 9.247 |
| Income in Advance | - | 0 | 0 | 0 | 3.864 | 1.998 | 311 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Aprophysio S.r.l.